Trial Profile
MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF THE RESECTION OF GLIOBLASTOMAS - THE RESECT STUDY
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Mar 2019
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Glioblastoma
- Focus Diagnostic use
- Acronyms RESECT
- 16 Mar 2019 Status changed from recruiting to completed.
- 03 Apr 2017 New trial record